These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20223816)

  • 1. Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis.
    Pérez-Bocanegra C; Solans-Laqué R; Simeón-Aznar CP; Campillo M; Fonollosa-Pla V; Vilardell-Tarrés M
    Rheumatology (Oxford); 2010 Jun; 49(6):1112-7. PubMed ID: 20223816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE; Almodovar R; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features.
    Valentini G; Cuomo G; Abignano G; Petrillo A; Vettori S; Capasso A; Cozzolino D; Del Genio G; Santoriello C
    Rheumatology (Oxford); 2011 Feb; 50(2):317-23. PubMed ID: 20562195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in causes of death in systemic sclerosis, 1972-2002.
    Steen VD; Medsger TA
    Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
    Czirják L; Kumánovics G; Varjú C; Nagy Z; Pákozdi A; Szekanecz Z; Szucs G
    Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.
    Sampaio-Barros PD; Bortoluzzo AB; Marangoni RG; Rocha LF; Del Rio AP; Samara AM; Yoshinari NH; Marques-Neto JF
    J Rheumatol; 2012 Oct; 39(10):1971-8. PubMed ID: 22896025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scleroderma--systemic sclerosis. Serology, lung function and survival].
    Ullman S; Halberg P; Wiik A; Jacobsen S
    Ugeskr Laeger; 1999 May; 161(21):3084-90. PubMed ID: 10377851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Causes of death of patients with systemic sclerosis].
    Chwieśko S; Sierakowski S; Kowal-Bielecka O
    Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.
    Ruangjutipopan S; Kasitanon N; Louthrenoo W; Sukitawut W; Wichainun R
    J Med Assoc Thai; 2002 Nov; 85(11):1204-9. PubMed ID: 12546318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis.
    Krause L; Becker MO; Brueckner CS; Bellinghausen CJ; Becker C; Schneider U; Haeupl T; Hanke K; Hensel-Wiegel K; Ebert H; Ziemer S; Ladner UM; Pirlich M; Burmester GR; Riemekasten G
    Ann Rheum Dis; 2010 Nov; 69(11):1951-7. PubMed ID: 20511612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.
    Poormoghim H; Andalib E; Jalali A; Ghaderi A; Ghorbannia A; Mojtabavi N
    Rheumatol Int; 2016 Jul; 36(7):925-34. PubMed ID: 27061806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia.
    Ashida R; Ihn H; Mimura Y; Jinnin M; Asano Y; Kubo M; Tamaki K
    Clin Exp Dermatol; 2009 Oct; 34(7):781-3. PubMed ID: 19508567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.